ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : University/Organization : Herbert Irving Comprehensive Cancer Center


Include trials that are no longer recruiting patients.

37 studies were found.
1.RecruitingCelecoxib in Preventing Skin Cancer
Conditions: basal cell carcinoma of the skin; squamous cell carcinoma of the skin
2.No longer recruitingChemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer
3.RecruitingChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis
Conditions: refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; primary systemic amyloidosis
4.RecruitingChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Central Nervous System Cancer
Conditions: adult brain tumor; paranasal sinus and nasal cavity cancer; primary central nervous system lymphoma
5.No longer recruitingCombination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
6.RecruitingCombination Chemotherapy Followed by Donor Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Genetic Disorders
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; plasma cell neoplasm
7.SuspendedCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia; ...
8.No longer recruitingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Conditions: relapsing chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
9.RecruitingCombination Chemotherapy in Treating Patients With Advanced Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
10.No longer recruitingComparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer
Conditions: stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer
11.No longer recruitingCP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
Conditions: stage IVB adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage III adult soft tissue sarcoma
12.No longer recruitingDocetaxel Combined With Estramustine in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer
13.No longer recruitingDocetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Endometrial Cancer; Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
14.No longer recruitingDocetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Conditions: adenocarcinoma of the prostate; Quality of Life; stage IV prostate cancer; recurrent prostate cancer
15.RecruitingGemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
Conditions: stage II pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; Nutrition; adenocarcinoma of the pancreas
16.CompletedGemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
17.No longer recruitingHigh-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer
Conditions: extensive stage small cell lung cancer; limited stage small cell lung cancer; stage IIIA non-small cell lung cancer; ...
18.No longer recruitingHormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
19.No longer recruitingInterferon alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma
Conditions: stage III adult soft tissue sarcoma; stage IVB adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage IIC adult soft tissue sarcoma; ...
20.No longer recruitingIrinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma
Conditions: stage IVB adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage IV adult soft tissue sarcoma
21.RecruitingPeripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Langerhans cell histiocytosis; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer
22.RecruitingSilymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy
Conditions: Drug Toxicity; childhood acute lymphoblastic leukemia
23.RecruitingStudy of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis
Condition: Amyloidosis
24.No longer recruitingSurgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
Conditions: localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
25.RecruitingTemozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
Conditions: adult soft tissue sarcoma; uterine leiomyosarcoma; uterine sarcoma
26.No longer recruitingTemozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: cellular diagnosis, adult soft tissue sarcoma; cellular diagnosis, uterine sarcoma; Cancer; stage, adult soft tissue sarcoma; ...
27.No longer recruitingTemozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
Conditions: recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult anaplastic astrocytoma
28.RecruitingThiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Malignant Glioma
Conditions: adult brain tumor; childhood brain tumor; childhood cerebellar astrocytoma; childhood cerebral astrocytoma and malignant glioma; childhood ependymoma; ...
29.No longer recruitingTopotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix
Conditions: recurrent cervical cancer; stage IVB cervical cancer; stage IVA cervical cancer; cervical squamous cell carcinoma; cervical adenocarcinoma
30.RecruitingUmbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
Conditions: Langerhans cell histiocytosis; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer
31.No longer recruitingVaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
Conditions: stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
32.No longer recruitingVaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma
Conditions: adult soft tissue sarcoma; adult synovial sarcoma
33.No longer recruitingVaccine Therapy in Treating Patients With Metastatic Melanoma
Conditions: Stage IV Melanoma; Recurrent Melanoma
34.RecruitingVaccine Therapy in Treating Patients With Metastatic Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
35.No longer recruitingVaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma
Conditions: stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
36.RecruitingZoledronate and Estradiol in Preventing Bone Loss in Patients With Prostate Cancer
Conditions: Osteoporosis; stage III prostate cancer; stage IV prostate cancer
37.RecruitingZoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
Conditions: Osteoporosis; stage I breast cancer; stage II breast cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act